These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 40013)

  • 1. Blood pressure and heart rate responses evoked by p-hydroxyamphetamine and by p-hydroxynorephedrine. I. The relationship between evoked responses and plasma levels of drug.
    Simpson LL
    J Pharmacol Exp Ther; 1979 Oct; 211(1):225-30. PubMed ID: 40013
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood pressure and heart rate response evoked by p-hydroxyamphetamine and by p-hydroxynorephedrine II. A quantitative assessment of the role of amphetamine metabolites in acute responses evoked by d-amphetamine.
    Simpson LL
    J Pharmacol Exp Ther; 1980 Jun; 213(3):504-8. PubMed ID: 7205614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of brain type A monoamine oxidase and 5-hydroxytryptamine uptake by two amphetamine metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine.
    Arai Y; Kim SK; Kinemuchi H; Tadano T; Satoh SE; Satoh N; Kisara K
    J Neurochem; 1990 Aug; 55(2):403-8. PubMed ID: 2370545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical effects of amphetamine metabolites on central dopaminergic and serotonergic systems.
    Matsuda LA; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1989 Dec; 251(3):901-8. PubMed ID: 2600821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative subcellular localization of para-hydroxylated derivatives of ephedrine and amphetamine in rat brain].
    El Guedri H; Rapin J; Jacquot C; Cohen Y
    C R Acad Hebd Seances Acad Sci D; 1975 Sep; 281(9):587-9. PubMed ID: 813909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence against the involvement of false neurotransmitters in tolerance to amphetamine-induced hyperthermia in the rat.
    Sever PS; Caldwell J; Williams RT
    J Pharm Pharmacol; 1974 Oct; 26(10):823-6. PubMed ID: 4156544
    [No Abstract]   [Full Text] [Related]  

  • 7. Radioimmunoassay of amphetamines in rat parotid saliva.
    Digregorio GJ; Kniaz EK
    Drug Alcohol Depend; 1976 Oct; 1(6):377-82. PubMed ID: 1017382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of hydroxylated metabolites in amphetamine-induced hypothermia in mice.
    Boschi G; Launay N; Rips R
    Gen Pharmacol; 1993 Jan; 24(1):59-67. PubMed ID: 8097741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of behavioral responses to methamphetamine evoked by the stimulant's metabolite p-hydroxynorephedrine in rats.
    Shimosato K; Watanabe S
    Pharmacol Biochem Behav; 1989 Jun; 33(2):423-9. PubMed ID: 2813480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist effects of beta-phenethylamines on the noradrenergic cyclic adenosine 3',5'-monophosphate generating system in rat limbic forebrain. Stereoisomers of p-hydroxynorephedrine.
    Smith HE; Burrows EP
    J Med Chem; 1977 Jul; 20(7):978-81. PubMed ID: 195059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synergism and antagonism of some sympathomimetic amines towards noradrenaline in vitro. Study on isolated rat seminal vesicle. II].
    Valette G
    C R Seances Soc Biol Fil; 1974; 168(10-11-12):1230-3. PubMed ID: 4283078
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence that a behavioral augmentation following repeated amphetamine administration does not involve peripheral mechanisms.
    Kuczenski R; Segal DS; Weinberger SB; Browne RG
    Pharmacol Biochem Behav; 1982 Sep; 17(3):547-53. PubMed ID: 6890688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of involvement of 4-hydroxynorephedrine in phenylpropanolamine-induced anorexia in rats.
    Rushing PA; Mittleman G
    Physiol Behav; 1993 Nov; 54(5):927-30. PubMed ID: 8248385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biochemistry of drugs. XXVII. Disposition and metabolism of p-hydroxynorephedrine-3H in rats].
    Ráz K; Smolík S; Vinarová M; Janda J; Franc Z
    Cesk Farm; 1979 Jun; 28(5):193-7. PubMed ID: 509565
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of catecholamine releasing agents on synaptosomal dopamine biosynthesis: multiple pools of dopamine or multiple forms of tyrosine hydroxylase.
    Kuczenski R
    Neuropharmacology; 1975 Jan; 14(1):1-10. PubMed ID: 239360
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of l-, d-, and parahydroxy-amphetamine on locomotor activity and wall climbing in rats of different ages.
    Bauer RH
    Pharmacol Biochem Behav; 1980 Aug; 13(2):155-65. PubMed ID: 7413685
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic antioxidant treatment improves sympathetic functions and beta-adrenergic pathway in the spontaneously hypertensive rats.
    Girouard H; Chulak C; LeJossec M; Lamontagne D; de Champlain J
    J Hypertens; 2003 Jan; 21(1):179-88. PubMed ID: 12544450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of dopamine efflux from rat striatal tissue caused by amphetamine and p-hydroxyamphetamine.
    Fischer JF; Cho AK
    Proc West Pharmacol Soc; 1976; 19():179-82. PubMed ID: 995984
    [No Abstract]   [Full Text] [Related]  

  • 19. The contribution of the metabolite p-hydroxyamphetamine to the central actions of p-methoxyamphetamine.
    Kaminskas LM; Irvine RJ; Callaghan PD; White JM; Kirkbride P
    Psychopharmacology (Berl); 2002 Mar; 160(2):155-60. PubMed ID: 11875633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mydriatic effectiveness of hydroxyamphetamine.
    Semes LP; Bartlett JD
    J Am Optom Assoc; 1982 Nov; 53(11):899-904. PubMed ID: 7175066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.